Clinical Trial Update: Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV [Phase 1]

View source ↗

Summary

Phase 1 exploratory trial assessing prophylactic efficacy of palivizumab in healthy adults inoculated with RSV; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Palivizumab (Palivizumab)

Snippet

Sponsor: mAbxience Research S.L. | Conditions: Healthy Adult Participants | Phase 1 | Status: COMPLETED | Results posted: 2021-10-04